human
TASK: Your task is to answer biomedical questions using the given abstract. Only output yes, no, or maybe as answer.
INPUT: ["It is now recognized that Crohn's disease (CD), similar to ulcerative colitis (UC), carries an up to 20-fold higher cancer risk, and the development of colorectal carcinoma (CRC) is a major long-term complication. Once CRC is present, molecular profiling is one of the components in selecting appropriate treatment strategies; however, in contrast to UC, genetic alterations in Crohn's colitis-associated CRC are poorly understood.", "In a series of 227 patients with Crohn's colitis, we identified 33 cases of CRC (~14\xa0%) and performed targeted mutational analysis of BRAF/KRAS/NRAS and determined microsatellite status as well as immunophenotype of the tumors.", "In the CRC cohort, the median age at time of cancer diagnosis was 58 (range 34-77 vs. 59.5 in sporadic; P\u2009=\u20090.81) and the median CD duration was 29\xa0years (range 6-45). As a group, CRC complicating Crohn's colitis is BRAF (97\xa0%) and NRAS (100\xa0%) wild type and the vast majority is microsatellite stable (94\xa0%); KRAS-mutations were found in six cases (18\xa0%). Stage grouping, anatomic distribution, and overall survival were similar to sporadic CRC; however, long-standing CD (≥25\xa0years) as well as gastric-immunophenotype (MUC5AC+) was associated with significantly shorter overall survival (P\u2009=\u20090.0029; P\u2009=\u20090.036, respectively)."] Is colorectal cancer in Crohn 's colitis comparable to sporadic colorectal cancer?
OUTPUT:

agent
yes
TASK: Your task is to answer biomedical questions using the given abstract. Only output yes, no, or maybe as answer.
INPUT: ["It is now recognized that Crohn's disease (CD), similar to ulcerative colitis (UC), carries an up to 20-fold higher cancer risk, and the development of colorectal carcinoma (CRC) is a major long-term complication. Once CRC is present, molecular profiling is one of the components in selecting appropriate treatment strategies; however, in contrast to UC, genetic alterations in Crohn's colitis-associated CRC are poorly understood.", "In a series of 227 patients with Crohn's colitis, we identified 33 cases of CRC (~14\xa0%) and performed targeted mutational analysis of BRAF/KRAS/NRAS and determined microsatellite status as well as immunophenotype of the tumors.", "In the CRC cohort, the median age at time of cancer diagnosis was 58 (range 34-77 vs. 59.5 in sporadic; P\u2009=\u20090.81) and the median CD duration was 29\xa0years (range 6-45). As a group, CRC complicating Crohn's colitis is BRAF (97\xa0%) and NRAS (100\xa0%) wild type and the vast majority is microsatellite stable (94\xa0%); KRAS-mutations were found in six cases (18\xa0%). Stage grouping, anatomic distribution, and overall survival were similar to sporadic CRC; however, long-standing CD (≥25\xa0years) as well as gastric-immunophenotype (MUC5AC+) was associated with significantly shorter overall survival (P\u2009=\u20090.0029; P\u2009=\u20090.036, respectively)."] Is colorectal cancer in Crohn 's colitis comparable to sporadic colorectal cancer?
OUTPUT:
